The field of regenerative medicine involves using human cells and tissues to restore normal function to the body. While bone marrow and skin transplants have been widely used for some time, the field is expanding rapidly. Today, biologics such as stem cells and platelets are being examined for their efficacy in treating everything from arthritis to cancer. While there is much promise in this field for the treatment of disease, there are major ethical concerns, particularly in regards to embryonic and fetal derived stem cells.
The Regenerative Medicine Initiative (RMI) of FISH is focused on fostering collaborative efforts between academic and clinical innovators in the field of regenerative medicine to develop and promote ethically sound therapies to treat disease.
The mission of the RMI is four-fold:
- To promote ethically sound regenerative medicine treatments that are consistent with the Church’s teaching and that will promote the culture of life;
- To perform basic research aimed at better understanding how to harness the regenerative properties of adult stem cells and other biologics; and
- To create opportunities for undergraduate students at Franciscan University of Steubenville to participate in cutting-edge research that has the potential to lead to clinical applications in this exciting field.
- To provide laboratory services for clinicians in the field of regenerative medicine.